
Data may be obtained from a third party and are not publicly available. This study used data from the Korean National Health Insurance Service (NHIS), which are not publicly available due to data protection regulations. Access to these data requires approval from the NHIS and is limited to authorised...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by recurrent flares, leading to progressive deterioration of multiple organ systems, including the kidneys, skin, joints, lungs, bowel, and central nervous system [1]. Among these manifestations, lupus nephritis (LN) develops...

Systemic lupus Erythematous (SLE) is the prototype of autoimmune systemic rheumatic disease with variable systemic manifestations. The haematological features range from anemia, leukopenia, thrombocytopenia to the rarer manifestations such as thrombotic thrombocytopenic purpura, autoimmune myelofibrosis,...

Systemic lupus erythematosus (SLE) is a complex, heterogeneous, and debilitating autoimmune disease characterized by the production of autoantibodies and the deposition of immune complexes [1]. Both innate and adaptive immune dysregulation contribute to its pathogenesis, leading to complement activation,...

Posterior reversible encephalopathy syndrome (PRES) is an acute or subacute encephalopathy syndrome that primarily manifests as headaches, seizures, and visual disturbances. The main causes of PRES include hypertension, end-stage renal disease, preeclampsia or eclampsia, systemic lupus erythematosus,...